Trials / Completed
CompletedNCT01104753
A Study of Pentasa in Patients With Ulcerative Colitis
Non-interventional Post Marketing Safety Study Confirming Efficacy and Safety of Pentasa Slow Release Tablets in Patients With Ulcerative Colitis in Common Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 338 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Confirmation of safety profile of Pentasa slow release tablets 500 mg in patients with ulcerative colitis (UC).
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-10-01
- Completion
- 2011-03-01
- First posted
- 2010-04-15
- Last updated
- 2011-04-07
Locations
30 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT01104753. Inclusion in this directory is not an endorsement.